标题
Small-Molecule Carbohydrate-Based Immunostimulants
作者
关键词
-
出版物
CHEMISTRY-A EUROPEAN JOURNAL
Volume 23, Issue 8, Pages 1728-1742
出版商
Wiley
发表日期
2016-07-07
DOI
10.1002/chem.201601539
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of Globo-H Cancer Vaccine
- (2015) Samuel J. Danishefsky et al. ACCOUNTS OF CHEMICAL RESEARCH
- MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS
- (2015) S. Schülke et al. ALLERGY
- Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation
- (2015) Jing Li et al. ChemMedChem
- C-type lectins in immunity: recent developments
- (2015) Ivy M Dambuza et al. CURRENT OPINION IN IMMUNOLOGY
- Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node–Resident Dendritic Cells for a Robust Adjuvant Effect
- (2015) Xiangming Li et al. JOURNAL OF IMMUNOLOGY
- Synthesis and Activity of 6″-Deoxy-6″-thio-α-GalCer and Peptide Conjugates
- (2015) Benjamin J. Compton et al. ORGANIC LETTERS
- Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
- (2015) Masaru TANIGUCHI et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8 + T-cell responses and prevent tumour progression
- (2015) Silke Neumann et al. VACCINE
- Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
- (2015) Yusuf Dölen et al. OncoImmunology
- Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus
- (2014) Jung-Tung Hung et al. ANTIVIRAL RESEARCH
- Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy
- (2014) M Singh et al. BRITISH JOURNAL OF CANCER
- Conjugation of a TLR7 agonist and antigen enhances protection in the S. pneumoniae murine infection model
- (2014) S. Vecchi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Optimizing NKT cell ligands as vaccine adjuvants
- (2014) Leandro J Carreño et al. Immunotherapy
- A New Era of Targeting the Ancient Gatekeepers of the Immune System: Toll-Like Agonists in the Treatment of Allergic Rhinitis and Asthma
- (2014) Zahra Aryan et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts
- (2014) Vincent Liu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeted Delivery of α-Galactosylceramide to CD8α+Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
- (2014) Elodie Macho-Fernandez et al. JOURNAL OF IMMUNOLOGY
- Development of αGlcN(1↔1)αMan-Based Lipid A Mimetics as a Novel Class of Potent Toll-like Receptor 4 Agonists
- (2014) Florian Adanitsch et al. JOURNAL OF MEDICINAL CHEMISTRY
- A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy
- (2014) Regan J Anderson et al. Nature Chemical Biology
- Improving Mycobacterium bovis Bacillus Calmette-Guèrin as a Vaccine Delivery Vector for Viral Antigens by Incorporation of Glycolipid Activators of NKT Cells
- (2014) Manjunatha M. Venkataswamy et al. PLoS One
- Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination
- (2014) Josianne Nitcheu Tefit et al. VACCINE
- Lipid antigens in immunity
- (2013) C. Marie Dowds et al. BIOLOGICAL CHEMISTRY
- Improving the immunostimulatory potency of diethanolamine-containing lipid A mimics
- (2013) Jordan D. Lewicky et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors
- (2013) Nicolas Isambert et al. BMC CANCER
- Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening
- (2013) Urban Švajger et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- TLR4 agonists as vaccine adjuvants: a chemist’s perspective
- (2013) David A Johnson Expert Review of Vaccines
- Pathogen Recognition Receptors: Ligands and Signaling Pathways by Toll-Like Receptors
- (2013) Miwa Sasai et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: The ESPIA questionnaire
- (2013) José Luis Justicia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Enhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor Protection
- (2013) S. Aspeslagh et al. JOURNAL OF IMMUNOLOGY
- Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update
- (2013) Francesco Peri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Vaccine Evaluation of the Tumor-Associated Carbohydrate Antigen RM2 from Prostate Cancer
- (2013) Hong-Yang Chuang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway
- (2013) Kurt Lucas et al. MOLECULAR NEUROBIOLOGY
- Stimulation of Natural Killer T Cells by Glycolipids
- (2013) Brian Anderson et al. MOLECULES
- The Yin and Yang of Toll-like receptors in cancer
- (2013) J-P Pradere et al. ONCOGENE
- A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates
- (2013) Neal N. Padte et al. PLoS One
- Toll-like Receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes
- (2013) Tatsuya Ando et al. Scientific Reports
- Silencing of TLR4 Increases Tumor Progression and Lung Metastasis in a Murine Model of Breast Cancer
- (2012) Abubakr Ahmed et al. ANNALS OF SURGICAL ONCOLOGY
- NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
- (2012) S. R. Mattarollo et al. BLOOD
- CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
- (2012) Stéphanie Corgnac et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adjuvants for human vaccines
- (2012) Carl R Alving et al. CURRENT OPINION IN IMMUNOLOGY
- Differential Expression of Toll-Like Receptor 2 on Dendritic Cells from Asymptomatic and Symptomatic Atopic Donors
- (2012) D. von Bubnoff et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- NMR Studies of Hexaacylated Endotoxin Bound to Wild-type and F126A Mutant MD-2 and MD-2·TLR4 Ectodomain Complexes
- (2012) Liping Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toll-like Receptor Activation of Human Cells by Synthetic Triacylated Lipid A-like Molecules
- (2012) Irène Dunn-Siegrist et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
- (2012) M. R. Hutchinson et al. JOURNAL OF NEUROSCIENCE
- Raising the Roof: The Preferential Pharmacological Stimulation of Th1 and Th2 Responses Mediated by NKT Cells
- (2012) James E. East et al. MEDICINAL RESEARCH REVIEWS
- Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2
- (2012) U. Ohto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist
- (2012) W. S. Bowen et al. Science Signaling
- Structural Biology of the Toll-Like Receptor Family
- (2011) Jin Young Kang et al. Annual Review of Biochemistry
- Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage
- (2011) María Pascual et al. BRAIN BEHAVIOR AND IMMUNITY
- A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity
- (2011) Matteo Piazza et al. ChemMedChem
- Sphingolipids and Glycosphingolipids — Their Synthesis and Bioactivities
- (2011) Kenji Mori et al. HETEROCYCLES
- The stimulating adventure of KRN 7000
- (2011) Aline Banchet-Cadeddu et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies
- (2011) A. J. Christiansen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection
- (2011) Natalie A. Parlane et al. VACCINE
- Exploring the LPS/TLR4 signal pathway with small molecules
- (2010) Francesco Peri et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Crosstalk of reactive oxygen species and NF-κB signaling
- (2010) Michael J Morgan et al. CELL RESEARCH
- Human lactoferrin activates NF-κB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling
- (2010) Ken Ando et al. FEBS Journal
- Pivotal Role of TLR4 Receptors in Alcohol-Induced Neuroinflammation and Brain Damage
- (2010) S. Alfonso-Loeches et al. JOURNAL OF NEUROSCIENCE
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
- (2010) N. Matsunaga et al. MOLECULAR PHARMACOLOGY
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- Silencing of TLR4 Decreases Liver Tumor Burden in a Murine Model of Colorectal Metastasis and Hepatic Steatosis
- (2009) T. M. Earl et al. ANNALS OF SURGICAL ONCOLOGY
- Evidence of a Specific Interaction between New Synthetic Antisepsis Agents and CD14
- (2009) Matteo Piazza et al. BIOCHEMISTRY
- Natural Killer T Cells and Autoimmune Disease
- (2009) Lan Wu et al. CURRENT MOLECULAR MEDICINE
- Resistin competes with lipopolysaccharide for binding to toll-like receptor 4
- (2009) Andrej Tarkowski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin
- (2009) M. M. Venkataswamy et al. JOURNAL OF IMMUNOLOGY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori
- (2009) Sonja I Gringhuis et al. NATURE IMMUNOLOGY
- Endotoxin tolerance: new mechanisms, molecules and clinical significance
- (2009) Subhra K. Biswas et al. TRENDS IN IMMUNOLOGY
- Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine
- (2009) Sarah A. Kopecky-Bromberg et al. VACCINE
- The role of Toll-like receptors in rheumatoid arthritis
- (2009) Qi-Quan Huang et al. Current Rheumatology Reports
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
- Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses
- (2008) Sandra J van Vliet et al. IMMUNOLOGY AND CELL BIOLOGY
- Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond
- (2008) Amit Lahiri et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started